Godfrey Wilson

Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial

Stephanie M. de Boer, Melanie Powell, Linda Mileshkin et al. · The Lancet Oncology · 2018 · 599 citations · Full text

Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial

Stephanie M. de Boer, Melanie Powell, Linda Mileshkin et al. · The Lancet Oncology · 2019 · 432 citations · Full text

Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva

Silvia de Sanjosé, Laia Alemany, Jaume Ordï et al. · European Journal of Cancer · 2013 · 381 citations · Full text

Vulvar Diseases, Human Papillomavirus Vaccines, Gynecology +7

Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer

Stephanie M. de Boer, Bastiaan G. Wortman, Tjalling Bosse et al. · Annals of Oncology · 2017 · 85 citations · Full text

A study of anal intraepithelial neoplasia in HIV positive homosexual men

H Lacey, Godfrey Wilson, Peter Tilston et al. · Sexually Transmitted Infections · 1999 · 82 citations · Full text